Detomold Medical, a division of Detmold Packaging a leading Australian manufacturer of paper and board based sustainable packaging products has engaged BioPortUSA to assist them with expanding their Global Sales. [...]
BioPortUSA News and Event Updates
BioPortUSA has signed a new partnership agreement with Seijgraaf BV, one of Hollands leading life science consultancies. Ron de Graaf, founder of Seijgraaf has over 36 years of experience working with over 600 health tech companies ranging in size from the Philips organization to start-ups.[...]
BioPortUSA has been tapped by BacTrace to help them launch their rapid Covid-19 antibody test, Racordiax in the USA. Manufactured in Germany, the CE-marked test provides a test result with 99.41% sensitivity and 99.13% specificity in just 10 minutes, using the appropriate smartphone iOS or Android RACORDIAX App. [...]
Mark Lesselroth, CEO of BioPortUSA was invited to participate in Bio-M webinar on Market Entry USA. Bio-M is Germany’s largest BioTech cluster and supports a number of early stage start-ups in the biotechnology arena.[...]
We asked AstraCon to join BioPort after working together with a mutual client that was German who needed help with Market Entry into the USA.[...]
Mark Lesselroth, the CEO of BioPortUSA participated in a Fireside Chat during the State of Baden-Württemberg’s Virtual Healthcare show [...]
Medica represents the world's largest medical device show which takes place every November in Düsseldorf Germany. Due to the Coronavirus this event has had to go virtual in 2020. As a result, Zenit along with enterprise europe network have created a virtual brokerage and education platform which will allow thousands of participants to come together and benefit from one another. [...]
Cerebriu, a Danish medical technology start-up focused on faster, personalized diagnostic imaging, engaged BioPort to help them identify a U.S. Radiology Department to conduct a pre-FDA pilot. We were fortunate enough to work with the leadership at SUNY Upstate to gain the interest of the Neuroradiology Department including Dr. Sylvie Destian. They have not only agreed to participate in a Retrospective Study pre-FDA but also be involved in a Prospective Clinical Trial to help achieve FDA approval.[...]
Social Media
Recent BioPortUSA News
Apr 8, 2024, 11:51 AM
Mar 20, 2024, 10:44 AM
Nov 8, 2023, 11:59 AM
Nov 6, 2023, 11:47 AM
Oct 2, 2023, 8:51 AM